Anglicheau D - Search Results

1

Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.

Lamarthée B, Marchal A, Charbonnier S, Blein T, Leon J, Martin E, Rabaux L, Vogt K, Titeux M, Delville M, Vinçon H, Six E, Pallet N, Michonneau D, Anglicheau D, Legendre C, Taupin JL, Nemazanyy I, Sawitzki B, Latour S, Cavazzana M, André I, Zuber J. Lamarthée B, et al. Among authors: anglicheau d. Nat Commun. 2021 Nov 8;12(1):6446. doi: 10.1038/s41467-021-26844-1. Nat Commun. 2021. PMID: 34750385 Free PMC article.

2

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: anglicheau d. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

3

Clinical consequences of the polymorphism of azathioprine metabolism.

Thervet E, Anglicheau D, Toledano N, Kreis H, Legendre C, Beaune P. Thervet E, et al. Among authors: anglicheau d. Transplant Proc. 2000 Dec;32(8):2780. doi: 10.1016/s0041-1345(00)01882-0. Transplant Proc. 2000. PMID: 11134802 No abstract available.

4

[Pharmacology of mycophenolate mofetil: recent data and clinical consequences].

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrologie. 2001;22(7):331-7. Nephrologie. 2001. PMID: 11817210 Review. French.

5

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.

Anglicheau D, Lautrette A, Scieux C, Thervet E, Martinez F, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Transplant Proc. 2002 Nov;34(7):2826-7. doi: 10.1016/s0041-1345(02)03531-5. Transplant Proc. 2002. PMID: 12431624 No abstract available.

6

Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.

Anglicheau D, Lautrette A, Scieux C, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Aug;18(8):1654-6. doi: 10.1093/ndt/gfg251. Nephrol Dial Transplant. 2003. PMID: 12897109

7

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Nov;18(11):2409-14. doi: 10.1093/ndt/gfg381. Nephrol Dial Transplant. 2003. PMID: 14551375

8

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.

Anglicheau D, Legendre C, Thervet E. Anglicheau D, et al. Transplantation. 2004 Aug 15;78(3):311-5. doi: 10.1097/01.tp.0000136256.56873.41. Transplantation. 2004. PMID: 15316356 Review.

9

Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability.

Pallet N, Thervet E, Le Corre D, Knebelmann B, Nusbaum P, Tomkiewicz C, Meria P, Flinois JP, Beaune P, Legendre C, Anglicheau D. Pallet N, et al. Among authors: anglicheau d. Kidney Int. 2005 Jun;67(6):2422-33. doi: 10.1111/j.1523-1755.2005.00350.x. Kidney Int. 2005. PMID: 15882288 Free article.

10

[Rapamycine and mTOR inhibitors: from bench to bedside].

Pallet N, Beaune P, Legendre C, Anglicheau D. Pallet N, et al. Among authors: anglicheau d. Ann Biol Clin (Paris). 2006 Mar-Apr;64(2):107-15. Ann Biol Clin (Paris). 2006. PMID: 16556521 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters